Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v28.i13.1288
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of death from cancer by 2030. Despite intensive research in the field of therapeutics, the 5-year overall survival is approximately 8%, with only… read more here.
Keywords: therapies effects; ductal adenocarcinoma; locoregional therapies; tumoral microenvironment ... See more keywords